Then, we identified 27 metabolites that were up-regulated or down-regulated in HFD group and simultaneously expressed in the opposite direction in HFDS group according to VIP and P-value
Where the Science Is Headed Now The next phase of the GLP-1 story is less about format and more about stability in the body over time, a shift that became tangible in December 2025 when the FDA approved Novo Nordisks oral semaglutide (Wegovy), the first daily GLP-1 pill cleared for obesity treatment
Nevertheless, aging is a privilege because we become wiser and more confident
Choose semaglutide when research requires a well-characterized single-receptor GLP-1 agonist with extensive published pharmacokinetic data, when establishing a baseline control condition for incretin research, or when studying GLP-1-specific CNS appetite signaling pathways
While tirzepatide, known in its branded form as Zepbound, is already available and FDA-approved, Retatrutide remains in clinical trials